@techcrunch.com 16 days ago
Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment
@xconomy.com 3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@slashgear.com 4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@engadget.com 5 years ago
E-cig makers have 60 days to show they aren’t targeting minors